Contract Pharmacal
United States 357 employees Updated 9 July 2026
Contract Pharmacal is a finished-dose manufacturer based in United States. It appears in 31 regulatory filings across 3 regulators, without an active US DMF or CEP on file. Its filings concentrate with US FDA, UZPHARM (UZ) and NPRA (MY). Its GMP standing is certified by NAFDAC (NG). Its most recent recorded inspection, by US FDA, closed on 14 April 2022 as VAI.
3
registered plants
1 with an FDA FEI number
31
filings
across 3 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
8 of 8 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.
Inspection history
- 14 April 2022 VAI US FDA
- 15 August 2017 NAI US FDA
- 9 December 2016 NAI US FDA
- 8 January 2015 NAI US FDA
- 4 December 2013 VAI US FDA
- 8 April 2013 NAI US FDA
- 7 February 2013 VAI US FDA
- 25 January 2012 VAI US FDA
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| Hauppauge New York, Nigeria | Not on file |
| HAUPPAUGE, NY, United States | Not on file |
| Hauppauge, United States | 2427358 |
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| US FDA | 25 | None |
| UZPHARM (UZ) | 5 | None |
| NPRA (MY) | 1 | None |
| NAFDAC (NG) | None | 1 |
Comparing suppliers?
Choose your molecules and target markets. Contract Pharmacal comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- 3 active litigation matters are on record.
- The most recent inspection outcome was VAI, on 14 April 2022.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- EudraGMDP and national regulators
- GMP certificates